XACT Robotics Announces Latest Financing Round Totaling $36M

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

November 13, 2019

XACT Robotics Ltd. today announced the successful completion of its latest financing round totaling $36 million. The company intends to use the proceeds to support the commercialization and continued development activities in support of the recent U.S. market cleared XACT Robotic System, which also has CE Mark. The XACT Robotic System is the first hands-free robotic system combining image-based planning and navigation with insertion and steering of various instruments to the desired target across an array of clinical applications and indications.

“As we continue to build momentum for our robotic system, we will use the recent funding to launch the system to select U.S. radiology Centers of Excellence partners,” said Chen Levin, CEO, XACT Robotics. “In addition, we will invest to continue expanding the utilization of the system and support our future launch cycle, including compatibility of the XACT Robotic System with additional imaging modalities and clinical applications to address a broad range of patient care needs.”

The current financing round included leading investors in the surgical robotics space, such as Chasing Value Asset Management Inc. (CA, USA) who previously held positions in MAKO Surgical Corp. (acquired by Stryker Corp. in 2013), Mazor Robotics (acquired by Medtronic in 2018), and most recently Corindus Vascular Robotics (acquired by Siemens in 2019). They join the current shareholders of the company including Shizim Group and MEDX Ventures Group.

XACT Robotics was founded by Harel Gadot, a renowned entrepreneur in the MedTech robotics space. The technology is based on research originally conducted at the Technion – Israel Institute of Technology, by Prof. Moshe Shoham, founder of Mazor Robotics (acquired by Medtronic in 2018).

The Company announced they will debut its technology at the 2019 Radiological Society of North America conference (RSNA) to be held in Chicago, IL on December 1 – 6, 2019 (exhibit booth #1650).

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.